(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1354037 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TRIB1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1332442 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIB1 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO RGD:1332442 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRIB1 mRNA CTD PMID:22206623 1-fluoro-2,4-dinitrobenzene increases expression ISO RGD:1354037 6480464 Dinitrofluorobenzene results in increased expression of TRIB1 mRNA CTD PMID:23999411 17beta-estradiol increases expression ISO RGD:1354037 6480464 Estradiol results in increased expression of TRIB1 mRNA CTD PMID:20106945 , PMID:31614463 17beta-estradiol decreases expression ISO RGD:1354037 6480464 Estradiol results in decreased expression of TRIB1 mRNA CTD PMID:19167446 17beta-estradiol multiple interactions ISO RGD:1354037 6480464 [Estradiol binds to ESR2 protein] which results in decreased expression of TRIB1 mRNA CTD PMID:20404318 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1354037 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1332442 6480464 Tetrachlorodibenzodioxin results in decreased expression of TRIB1 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TRIB1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IFIT1 mRNA, Tetrachlorodibenzodioxin results in increased expression of TRIB1 mRNA CTD PMID:15644576 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1354037 6480464 Tetrachlorodibenzodioxin results in decreased expression of TRIB1 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TRIB1 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of TRIB1 mRNA CTD PMID:21346803 2-amino-4,6-dinitrotoluene affects expression EXP 6480464 2-amino-4, 6-dinitrotoluene affects the expression of TRIB1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1354037 6480464 Lactic Acid results in increased expression of TRIB1 mRNA CTD PMID:30851411 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of IFIT1 mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1354037 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIB1 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:1332442 6480464 4, 4'-diaminodiphenylmethane results in increased expression of TRIB1 mRNA CTD PMID:18648102 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1354037 6480464 Oxazolone results in increased expression of TRIB1 mRNA CTD PMID:23999411 4-hydroxyphenyl retinamide increases expression ISO RGD:1332442 6480464 Fenretinide results in increased expression of TRIB1 mRNA CTD PMID:28973697 5-azacytidine decreases expression ISO RGD:1354037 6480464 Azacitidine results in decreased expression of TRIB1 mRNA CTD PMID:19194470 acetamide affects expression EXP 6480464 acetamide affects the expression of IFIT1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1354037 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIB1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIB1 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of TRIB1 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1354037 6480464 Acrylamide results in increased expression of TRIB1 mRNA CTD PMID:32763439 acrylamide increases expression ISO RGD:1332442 6480464 Acrylamide results in increased expression of TRIB1 mRNA CTD PMID:30807115 afimoxifene decreases response to substance ISO RGD:1354037 6480464 TRIB1 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1354037 6480464 Aflatoxin B1 affects the expression of TRIB1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TRIB1 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:1354037 6480464 Aflatoxin B1 results in increased methylation of TRIB1 polyA tail CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:1354037 6480464 Aflatoxin B1 results in increased expression of TRIB1 mRNA CTD PMID:21641981 aflatoxin B1 increases expression ISO RGD:1332442 6480464 Aflatoxin B1 results in increased expression of TRIB1 mRNA CTD PMID:19770486 Aflatoxin B2 alpha increases methylation ISO RGD:1354037 6480464 aflatoxin B2 results in increased methylation of TRIB1 polyA tail CTD PMID:30157460 all-trans-retinoic acid affects expression ISO RGD:1354037 6480464 Tretinoin affects the expression of TRIB1 mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO RGD:1354037 6480464 Tretinoin results in increased expression of TRIB1 mRNA CTD PMID:23724009 , PMID:33167477 alpha-pinene multiple interactions ISO RGD:1354037 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIB1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIB1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IFIT1 mRNA, Ammonium Chloride affects the expression of TRIB1 mRNA CTD PMID:16483693 antimycin A increases expression ISO RGD:1354037 6480464 Antimycin A results in increased expression of TRIB1 mRNA CTD PMID:33512557 antirheumatic drug decreases expression ISO RGD:1354037 6480464 Antirheumatic Agents results in decreased expression of TRIB1 mRNA CTD PMID:24449571 arsane affects expression ISO RGD:1354037 6480464 Arsenic affects the expression of TRIB1 mRNA CTD PMID:25304211 arsane affects methylation ISO RGD:1354037 6480464 Arsenic affects the methylation of TRIB1 gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:1354037 6480464 Arsenic affects the expression of TRIB1 mRNA CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1354037 6480464 Arsenic affects the methylation of TRIB1 gene CTD PMID:25304211 arsenite(3-) decreases methylation ISO RGD:1354037 6480464 arsenite results in decreased methylation of TRIB1 promoter CTD PMID:23974009 atrazine decreases expression ISO RGD:1354037 6480464 Atrazine results in decreased expression of TRIB1 mRNA CTD PMID:22378314 azathioprine increases expression ISO RGD:1354037 6480464 Azathioprine results in increased expression of TRIB1 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO RGD:1354037 6480464 Benzo(a)pyrene results in increased expression of TRIB1 mRNA CTD PMID:20064835 more ... benzo[a]pyrene increases methylation ISO RGD:1354037 6480464 Benzo(a)pyrene results in increased methylation of TRIB1 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1354037 6480464 7 more ... CTD PMID:26238291 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IFIT1 mRNA, bisphenol A results in decreased expression of TRIB1 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:1332442 6480464 bisphenol A results in increased expression of TRIB1 mRNA CTD PMID:32156529 bisphenol A affects expression ISO RGD:1354037 6480464 bisphenol A affects the expression of TRIB1 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of IFIT1 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1354037 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIB1 mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:1332442 6480464 bisphenol A results in decreased expression of TRIB1 mRNA CTD PMID:25594700 butan-1-ol multiple interactions ISO RGD:1354037 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TRIB1 mRNA CTD PMID:29432896 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of TRIB1 mRNA CTD PMID:19167457 cadmium atom decreases expression ISO RGD:1354037 6480464 Cadmium results in decreased expression of TRIB1 mRNA CTD PMID:24376830 calcitriol increases expression ISO RGD:1354037 6480464 Calcitriol results in increased expression of TRIB1 mRNA CTD PMID:16002434 cannabidiol increases expression ISO RGD:1354037 6480464 Cannabidiol results in increased expression of TRIB1 mRNA CTD PMID:33244087 carbon nanotube decreases expression ISO RGD:1332442 6480464 Nanotubes, Carbon results in decreased expression of TRIB1 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1332442 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin increases expression ISO RGD:1354037 6480464 chloropicrin results in increased expression of TRIB1 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1332442 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TRIB1 mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:1354037 6480464 Cisplatin results in decreased expression of TRIB1 mRNA CTD PMID:27392435 , PMID:27594783 cisplatin multiple interactions ISO RGD:1354037 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of TRIB1 mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1354037 6480464 cobaltous chloride results in increased expression of TRIB1 mRNA CTD PMID:19320972 cocaine affects expression EXP 6480464 Cocaine affects the expression of TRIB1 mRNA CTD PMID:20187946 copper atom increases expression EXP 6480464 Copper results in increased expression of TRIB1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of TRIB1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1354037 6480464 Copper Sulfate results in increased expression of TRIB1 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1354037 6480464 Coumestrol results in decreased expression of TRIB1 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1354037 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO RGD:1354037 6480464 Asbestos, Crocidolite affects the expression of TRIB1 mRNA CTD PMID:17331233 crocidolite asbestos increases expression ISO RGD:1354037 6480464 Asbestos, Crocidolite results in increased expression of TRIB1 mRNA CTD PMID:18687144 cyclosporin A increases expression ISO RGD:1354037 6480464 Cyclosporine results in increased expression of TRIB1 mRNA CTD PMID:20106945 more ... deguelin decreases expression ISO RGD:1354037 6480464 deguelin results in decreased expression of TRIB1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:1354037 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIB1 mRNA CTD PMID:28628672 dibenz[a,h]anthracene increases expression ISO RGD:1332442 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of TRIB1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1332442 6480464 Dibutyl Phthalate results in increased expression of TRIB1 mRNA CTD PMID:17361019 , PMID:21266533 diethyl maleate increases expression ISO RGD:1354037 6480464 diethyl maleate results in increased expression of TRIB1 mRNA CTD PMID:33545341 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFIT1 mRNA], [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFIT1 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO RGD:1332442 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIB1 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1354037 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of IFIT1 mRNA CTD PMID:32289291 doxorubicin decreases expression ISO RGD:1354037 6480464 Doxorubicin results in decreased expression of TRIB1 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:1354037 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA CTD PMID:19167446 Enterolactone decreases expression ISO RGD:1354037 6480464 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TRIB1 mRNA CTD PMID:19167446 epoxiconazole decreases expression ISO RGD:1332442 6480464 epoxiconazole results in decreased expression of TRIB1 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1332442 6480464 Ethanol affects the expression of and affects the splicing of TRIB1 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1332442 6480464 Ethanol affects the expression of TRIB1 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1354037 6480464 Ethyl Methanesulfonate results in decreased expression of TRIB1 mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO RGD:1332442 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRIB1 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1332442 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:1332442 6480464 Folic Acid results in decreased expression of TRIB1 mRNA CTD PMID:25629700 folpet increases expression ISO RGD:1332442 6480464 folpet results in increased expression of TRIB1 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:1354037 6480464 Formaldehyde results in increased expression of TRIB1 mRNA CTD PMID:17938736 , PMID:27664576 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IFIT1 mRNA CTD PMID:33387578 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of TRIB1 mRNA CTD PMID:24915197 hydrogen peroxide affects expression ISO RGD:1354037 6480464 Hydrogen Peroxide affects the expression of TRIB1 mRNA CTD PMID:20044591 hydroquinone increases expression ISO RGD:1354037 6480464 hydroquinone results in increased expression of TRIB1 mRNA CTD PMID:31256213 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRIB1 mRNA CTD PMID:22129741 indometacin multiple interactions ISO RGD:1354037 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIB1 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1332442 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TRIB1 mRNA CTD PMID:36331819 irinotecan increases expression ISO RGD:1354037 6480464 Irinotecan analog results in increased expression of TRIB1 mRNA CTD PMID:18927307 L-methionine multiple interactions ISO RGD:1332442 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TRIB1 mRNA CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of IFIT1 mRNA CTD PMID:22641619 leflunomide increases expression ISO RGD:1354037 6480464 leflunomide results in increased expression of TRIB1 mRNA CTD PMID:28988120 melphalan increases expression ISO RGD:1354037 6480464 Melphalan results in increased expression of TRIB1 mRNA CTD PMID:22363485 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of IFIT1 mRNA CTD PMID:23358152 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of TRIB1 mRNA CTD PMID:16507785 methotrexate decreases expression ISO RGD:1354037 6480464 Methotrexate results in decreased expression of TRIB1 mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO RGD:1354037 6480464 Methyl Methanesulfonate results in decreased expression of TRIB1 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO RGD:1354037 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of TRIB1 mRNA CTD PMID:31629900 methylseleninic acid decreases expression ISO RGD:1354037 6480464 methylselenic acid results in decreased expression of TRIB1 mRNA CTD PMID:18548127 mitoxantrone affects response to substance ISO RGD:1354037 6480464 TRIB1 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 monosodium L-glutamate decreases expression ISO RGD:1332442 6480464 Sodium Glutamate results in decreased expression of TRIB1 mRNA CTD PMID:22078008 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRIB1 mRNA CTD PMID:22129741 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TRIB1 mRNA CTD PMID:28801915 N-nitrosodiethylamine decreases expression ISO RGD:1332442 6480464 Diethylnitrosamine results in decreased expression of TRIB1 mRNA CTD PMID:18691550 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRIB1 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions ISO RGD:1332442 6480464 IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of TRIB1 mRNA], MAPK14 protein inhibits the reaction [Diethylnitrosamine results in decreased expression of TRIB1 mRNA] CTD PMID:18691550 N-nitrosodimethylamine increases expression ISO RGD:1354037 6480464 Dimethylnitrosamine results in increased expression of TRIB1 mRNA CTD PMID:17547211 N-Nitrosopyrrolidine increases expression ISO RGD:1354037 6480464 N-Nitrosopyrrolidine results in increased expression of TRIB1 mRNA CTD PMID:32234424 nickel dichloride increases expression ISO RGD:1354037 6480464 nickel chloride results in increased expression of TRIB1 mRNA CTD PMID:17547211 oxaliplatin multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of IFIT1 mRNA, [Oxaliplatin co-treated with Topotecan] results in increased expression of TRIB1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1354037 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIB1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1332442 6480464 Acetaminophen affects the expression of TRIB1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TRIB1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1354037 6480464 Acetaminophen results in increased expression of TRIB1 mRNA CTD PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of TRIB1 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1332442 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIB1 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:1354037 6480464 perfluorooctanoic acid results in decreased expression of TRIB1 mRNA CTD PMID:36326898 phenobarbital decreases expression ISO RGD:1332442 6480464 Phenobarbital results in decreased expression of TRIB1 mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:1354037 6480464 Phenobarbital affects the expression of TRIB1 mRNA CTD PMID:19159669 phenol increases expression ISO RGD:1354037 6480464 Phenol results in increased expression of TRIB1 mRNA CTD PMID:17547211 phenylmercury acetate decreases expression ISO RGD:1354037 6480464 Phenylmercuric Acetate results in decreased expression of TRIB1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1354037 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIB1 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1332442 6480464 pirinixic acid results in increased expression of TRIB1 mRNA CTD PMID:18445702 pirinixic acid decreases expression ISO RGD:1332442 6480464 pirinixic acid results in decreased expression of TRIB1 mRNA CTD PMID:23811191 potassium chromate increases expression ISO RGD:1354037 6480464 potassium chromate(VI) results in increased expression of TRIB1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1354037 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TRIB1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1332442 6480464 Pregnenolone Carbonitrile results in increased expression of TRIB1 mRNA CTD PMID:28903501 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of IFIT1 mRNA CTD PMID:23358152 rac-lactic acid increases expression ISO RGD:1354037 6480464 Lactic Acid results in increased expression of TRIB1 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:1354037 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of TRIB1 mRNA CTD PMID:19059307 SB 431542 multiple interactions ISO RGD:1354037 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1332442 6480464 Silicon Dioxide results in increased expression of TRIB1 mRNA CTD PMID:19073995 , PMID:33720480 silicon dioxide decreases methylation ISO RGD:1354037 6480464 Silicon Dioxide results in decreased methylation of TRIB1 gene CTD PMID:34973136 silver atom increases expression ISO RGD:1354037 6480464 Silver results in increased expression of TRIB1 mRNA CTD PMID:28959546 silver(0) increases expression ISO RGD:1354037 6480464 Silver results in increased expression of TRIB1 mRNA CTD PMID:28959546 sodium arsenite decreases expression ISO RGD:1354037 6480464 sodium arsenite results in decreased expression of TRIB1 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1332442 6480464 sodium arsenite results in increased expression of TRIB1 mRNA CTD PMID:36209798 sotorasib multiple interactions ISO RGD:1354037 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TRIB1 mRNA CTD PMID:36139627 sunitinib decreases expression ISO RGD:1354037 6480464 Sunitinib results in decreased expression of TRIB1 mRNA CTD PMID:31533062 tamibarotene affects expression ISO RGD:1354037 6480464 tamibarotene affects the expression of TRIB1 mRNA CTD PMID:15498508 tamoxifen multiple interactions ISO RGD:1354037 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of TRIB1 mRNA CTD PMID:19059307 temozolomide increases expression ISO RGD:1354037 6480464 Temozolomide results in increased expression of TRIB1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:1354037 6480464 tert-Butylhydroperoxide results in increased expression of TRIB1 mRNA CTD PMID:15336504 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of IFIT1 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1332442 6480464 Carbon Tetrachloride results in increased expression of TRIB1 mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:1354037 6480464 Thapsigargin results in increased expression of TRIB1 mRNA CTD PMID:29453283 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TRIB1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1332442 6480464 titanium dioxide results in decreased expression of TRIB1 mRNA CTD PMID:29264374 topotecan increases expression EXP 6480464 Topotecan results in increased expression of IFIT1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of IFIT1 mRNA, [Oxaliplatin co-treated with Topotecan] results in increased expression of TRIB1 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1354037 6480464 torcetrapib results in increased expression of TRIB1 mRNA CTD PMID:23228038 trametinib multiple interactions ISO RGD:1354037 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TRIB1 mRNA CTD PMID:36139627 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of IFIT1 mRNA, Trichloroethylene results in increased expression of TRIB1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1354037 6480464 trichostatin A results in decreased expression of TRIB1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1354037 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIB1 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1354037 6480464 Triclosan results in decreased expression of TRIB1 mRNA CTD PMID:30510588 Triptolide increases expression EXP 6480464 triptolide results in increased expression of IFIT1 protein CTD PMID:32519852 triptonide increases expression ISO RGD:1332442 6480464 triptonide results in increased expression of TRIB1 mRNA CTD PMID:33045310 urethane increases expression ISO RGD:1354037 6480464 Urethane results in increased expression of TRIB1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1332442 6480464 Valproic Acid affects the expression of TRIB1 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1354037 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIB1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1354037 6480464 Valproic Acid results in decreased expression of TRIB1 mRNA CTD PMID:23179753 , PMID:26272509 valproic acid affects expression ISO RGD:1354037 6480464 Valproic Acid affects the expression of TRIB1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1332442 6480464 Valproic Acid results in decreased expression of TRIB1 mRNA CTD PMID:19136453 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TRIB1 mRNA CTD PMID:23034163 vincristine decreases expression ISO RGD:1354037 6480464 Vincristine results in decreased expression of TRIB1 mRNA CTD PMID:23649840 vorinostat multiple interactions ISO RGD:1354037 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIB1 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1354037 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TRIB1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1354037 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TRIB1 mRNA CTD PMID:18593933